Literature DB >> 23989132

Radiation therapy: posterior segment complications.

Stefan Seregard1, David E Pelayes, Arun D Singh.   

Abstract

Therapeutic radiation to the posterior segment of the eye is a common option for posterior segment tumors. Such tumors are often malignant, but sometimes, benign neoplasms are treated with ionizing radiation. Also, non-neoplastic intraocular lesions like wet age-related macular degeneration may be treated with radiotherapy. Orbital disease, both neoplastic lesions like optic nerve sheath meningioma and non-neoplastic entities like Graves' ophthalmopathy may be treated with radiotherapy and this may include radiation of the optic nerve and posterior segment of the eye. Occasionally, radiotherapy of extraocular malignant disease, involving, e.g. the paranasal sinuses, may cause significant radiation damage to the eye. Complications after radiation to the posterior segment of the eye are largely related to the radiation dose to the posterior segment. The amount of irradiated volume of normal tissue and fractionation are also important for the development of radiation complications to the posterior segment. Radiation retinopathy is the most common complication of the posterior segment, but radiation optic neuropathy also occurs frequently. Radiation scleral necrosis is less frequent probably due to the radioresistance of the scleral collagen. These complications have the potential to cause blindness (radiation retinopathy and optic neuropathy) or enucleation of the eye (scleral necrosis). Although numerous treatments have been advocated, management of radiation-induced damage remains controversial. Efficacy for any treatment still needs to be proven and, if possible, the best option by far is to minimize radiation changes to normal tissue.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23989132     DOI: 10.1159/000351088

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  5 in total

Review 1.  Uveal Melanoma: Current Trends in Diagnosis and Management.

Authors:  Berçin Tarlan; Hayyam Kıratlı
Journal:  Turk J Ophthalmol       Date:  2016-06-06

2.  Glioma-associated radiation retinopathy treated successfully with aflibercept.

Authors:  D Karagiannis; L Kontomichos; I Georgalas; V Peponis; E Antoniou; E Parikakis
Journal:  Ther Clin Risk Manag       Date:  2019-07-26       Impact factor: 2.423

Review 3.  Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update.

Authors:  Andrew G Lee; Thomas H Mader; C Robert Gibson; William Tarver; Pejman Rabiei; Roy F Riascos; Laura A Galdamez; Tyson Brunstetter
Journal:  NPJ Microgravity       Date:  2020-02-07       Impact factor: 4.415

Review 4.  Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.

Authors:  Yunyun Cheng; Wanqiao Li; Ruirui Gui; Chunli Wang; Jie Song; Zhaoguo Wang; Xue Wang; Yannan Shen; Zhicheng Wang; Linlin Hao
Journal:  Front Cell Dev Biol       Date:  2021-06-09

5.  Delayed visual loss due to radiation retinopathy.

Authors:  Salih Uzun; Sami Toyran; Fahrettin Akay; Fatih C Gundogan
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.